Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues	$ 35,667,982	$ 33,978,425
Cost of Revenues	21,184,579	21,537,572
Gross Profit	14,483,403	12,440,853
Operating Expenses:
Advertising	414,194	83,993
Payroll and related expense	6,634,800	6,991,095
Rent, utilities and property maintenance	3,102,484	3,464,516
Hauling and equipment maintenance	2,898,202	3,378,452
Impairment of intangible assets		2,499,753
Depreciation and amortization expense	5,814,880	4,061,404
Consulting, accounting and legal	1,713,613	897,981
Loss on asset (related-party and other of $9,850,850 and $197,458, respectively)	10,048,308
Common stock issued for services	171,239
Other general and administrative expenses	3,200,445	1,946,580
Total Operating Expenses	33,998,165	23,323,774
Loss From Operations	(19,514,762)	(10,882,921)
Other Income (Expense):
Interest expense and amortization of debt discount	(8,897,267)	(34,079,230)
Other gain (loss)	17,572	(79,231)
Gain on tax credit	717,064
Gain on lease termination	108,863
Change in fair value of derivative liabilities		14,264,476
Warrant expense for liquidated damages settlements		(7,408,681)
Gain on conversion of convertible notes		2,625,378
Gain (loss) on settlement of convertible notes payable and accrued interest, warrants and accounts payable and cancelation of common shares in exchange for Series Y and Series Z preferred shares and cash	632,540	516,920
Total Other Income (Expense)	(7,421,228)	(24,160,368)
Net Loss Before Income Taxes	(26,935,990)	(35,043,290)
Provision for Income Taxes (Benefit)
Net Loss	(26,935,990)	(35,043,290)
Deemed dividend for the reduction of exercise price of warrants	(1,638,952)
Deemed dividend for the reduction of the conversion price of a debt note	(5,022,200)
Deemed dividend for Series Z price protection trigger upon uplisting		(7,237,572)
Deemed dividend for triggering of warrant price protection upon uplisting		(21,115,910)
Deemed dividend for repricing of certain warrants for liquidated damages waiver		(462,556)
Net Loss Available to Common Stockholders	$ (33,597,142)	$ (63,859,328)
Net Loss Per Common Share:
Basic	$ (2.57)	$ (9.71)
Diluted	$ (2.57)	$ (9.71)
Weighted Average Common Shares Outstanding:
Basic	13,062,290	6,577,303
Diluted	13,062,290	6,577,303